BioLago’s ‘Science meets business’ event makes successful return 

Audience

After a two-year break, the cross-border health network BioLago’s in-person forum returned: ‘Science meets business’ took place 8 July 2022 at the University of Konstanz, Germany.  

Around 70 people attended the afternoon forum and networking event, with visitors ranging from technology and service providers, academics, researchers, and laboratory management professionals. The event was also attended by chemical biology graduate students from the University of Konstanz. 

The focus of the event was on the Covid-19 pandemic and aimed to address the questions of what lessons can we learn and what is the outlook for the future. Keynote speakers included Professor Dr. Klaus Cichutek, President of the Paul-Ehrlich-Institute who spoke about fighting the Covid-19 pandemic and Proessor Heinrich Haas, Vice President Formulation and Drug Delivery at BioNTech SE who spoke on the topic of nanotechnologies in the development of vaccines against cancer. There were also presentations from Eurofins Genomics Sequencing GmbH and ceGat GmbH. 

The event was supported by Eurofins Genomics, University of Konstanz, Takeda and Microsynth. 

 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free